News Category
NOLA Pediatric Dentistry's new online page helps Mandeville families understand pediatric dental services including exams, sealants, and laser frenect...
MediKeeper's Chief Health and Strategy Officer, Dr. Tyler Amell, will speak at multiple international conferences on workplace health and productivity...
Purple Exhibits managed every phase of Amazon's first-ever immersive brand activation at the ESSENCE Festival, demonstrating its full-service capabili...
Commercial fisherman Victor Daniel Silva highlights the importance of individual choices in supporting Gulf Coast ecosystems and seafood sustainabilit...
Artist Pam Skehan’s works, displayed at Wine Art Gallery, have been chosen by Met Museum curators for the 15th annual Louisiana Contemporary exhibitio...
The Italian Barrel in New Orleans' French Quarter has been recognized with Wine Spectator's Award of Excellence for its outstanding wine program, refl...
Stroke patients treated with loberamisal within 48 hours had significantly better functional outcomes at 90 days, offering a potential new treatment t...
A new study presented at the American Stroke Association's International Stroke Conference 2026 found that high-dose constraint-induced movement thera...
Phase III trial shows asundexian, a Factor XI inhibitor, added to antiplatelet therapy reduces secondary ischemic stroke risk by 26% without increasin...
A new trial shows that infusing alteplase into the brain artery after mechanical thrombectomy significantly increases the likelihood of excellent func...
The American Stroke Association recognized 11 scientists with top awards at the International Stroke Conference 2026 for their exceptional contributio...
The American Stroke Association has announced five pre-conference symposia ahead of the International Stroke Conference 2026, covering topics from str...
Freedom at The Mat launches its first AI-generated brand anthem, 'Grace As I Grow,' engineered to induce theta brainwave states for deep relaxation an...
A quality improvement program integrating health coaches and multidisciplinary teams led to significant LDL cholesterol reductions in veterans with he...
A new study presented at the American Heart Association’s Scientific Sessions 2025 reveals that providing medically tailored meals or fresh produce bo...
A new clinical trial presented at the American Heart Association's Scientific Sessions 2025 found that adding the PCSK9 inhibitor alirocumab to a stat...
A study presented at the American Heart Association’s Scientific Sessions 2025 found that a once-daily polypill combining three heart failure medicati...
Stress cardiac MRI testing reveals microvascular angina in patients with chest pain but no blocked main arteries, leading to better diagnosis and sign...
A study presented at the American Heart Association's Scientific Sessions 2025 found that a program combining home-delivered DASH diet groceries with ...
A study of 400 adults with high blood pressure found that daily cash rewards doubled medication adherence but did not significantly improve blood pres...
A new study shows that personalized vitamin D supplementation targeting optimal blood levels reduces heart attack risk by 52% in adults with heart dis...
The TOP trial found that earlier blood transfusion (hemoglobin below 10 g/dL) after major surgery did not affect severe complications but was associat...
A new study presented at the American Heart Association's Scientific Sessions 2025 found that successful catheter ablation reduces stroke risk in AFib...
A new study presented at the American Heart Association’s Scientific Sessions 2025 found that for older patients with atrial fibrillation at high risk...
A new study presented at the American Heart Association’s Scientific Sessions 2025 found that a one-month course of dual antiplatelet therapy followed...
A phase 3 trial presented at the American Heart Association’s Scientific Sessions 2025 shows that the oral medication enlicitide reduces LDL cholester...
The VESALIUS-CV trial shows that adding evolocumab to high-intensity lipid-lowering therapy reduces the risk of coronary heart disease death, heart at...
A Phase 2 trial of DR10624, a first-in-class triple agonist targeting FGF21, glucagon, and GLP-1 receptors, showed over 60% reduction in triglycerides...
An AI algorithm accurately identified structural heart diseases using single-lead ECGs from a smartwatch in a prospective study of 600 adults, potenti...
